Clinical Trial Update: Pediatric Hydroxyurea Phase III Clinical Trial (BABY HUG) Follow-up Observational Study II Protocol

View source ↗

Summary

Follow-up observational protocol for pediatric hydroxyurea (BABY HUG) Phase III trial in sickle cell anemia; study completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• HYDROXYUREA (Hydroxyurea)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Sickle Cell Anemia | Status: COMPLETED | Results posted: 2020-08-20